A detailed history of Allspring Global Investments Holdings, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 2,124 shares of PRTA stock, worth $43,308. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,124
Previous 2,124 -0.0%
Holding current value
$43,308
Previous $52,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

BUY
$24.75 - $40.66 $4,380 - $7,196
177 Added 9.09%
2,124 $52,000
Q4 2023

Jan 25, 2024

SELL
$32.31 - $52.32 $37,124 - $60,115
-1,149 Reduced 37.11%
1,947 $70,000
Q3 2023

Oct 27, 2023

BUY
$47.3 - $70.6 $146,440 - $218,577
3,096 New
3,096 $149,000
Q2 2023

Jul 18, 2023

SELL
$48.26 - $78.59 $148,158 - $241,271
-3,070 Reduced 61.08%
1,956 $133,000
Q1 2023

Apr 13, 2023

SELL
$46.97 - $58.27 $91,967 - $114,092
-1,958 Reduced 28.04%
5,026 $243,000
Q4 2022

Jan 23, 2023

SELL
$52.05 - $65.0 $300,484 - $375,245
-5,773 Reduced 45.25%
6,984 $421 Million
Q3 2022

Oct 26, 2022

SELL
$25.16 - $60.63 $8,831 - $21,281
-351 Reduced 2.68%
12,757 $773,000
Q2 2022

Jul 25, 2022

SELL
$22.73 - $39.98 $288,466 - $507,386
-12,691 Reduced 49.19%
13,108 $355,000
Q1 2022

May 02, 2022

SELL
$30.27 - $49.22 $2.17 Million - $3.52 Million
-71,533 Reduced 73.49%
25,799 $943,000
Q4 2021

Jan 28, 2022

BUY
$42.11 - $73.26 $4.1 Million - $7.13 Million
97,332 New
97,332 $4.81 Million

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $957M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.